Stanford agentic AI scientists reshape drug discovery

Stanford researchers built agentic AI 'scientists' to automate drug discovery workflows. The system addresses the 90% to 95% failure rate and multi-billion-dollar costs of traditional drug development. The researchers will present their work at VB Transform 2026.